JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB128434

Recombinant Human EAP30 protein (His tag N-Terminus)

Recombinant Human EAP30 protein (His tag N-Terminus)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human EAP30 protein (His tag N-Terminus) is a Human Full Length protein, in the 1 to 258 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.

別名を表示する

EAP30, SNF8, Vacuolar-sorting protein SNF8, ELL-associated protein of 30 kDa, ESCRT-II complex subunit VPS22, hVps22

1 Images
SDS-PAGE - Recombinant Human EAP30 protein (His tag N-Terminus) (AB128434)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant Human EAP30 protein (His tag N-Terminus) (AB128434)

Analysis of ab128434 (Human EAP30 protein) on a 15% SDS-PAGE gel : Lane 1 : MW marker
Lane 2 ab128434 at 3 μg

Key facts

精製度

>90% SDS-PAGE

Purified by conventional chromatography techniques.

発現系

Escherichia coli

タグ

His tag N-Terminus

アプリケーション

Mass Spec, SDS-PAGE

applications

生物活性

No

アクセッション番号

Q96H20

アニマルフリー

No

キャリアフリー

No

種

Human

バッファー組成

pH: 8 Constituents: 50% Glycerol (glycerin, glycerine), 1.16% Sodium chloride, 0.32% Tris HCl, 0.03% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

storage-buffer

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "Mass Spec": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column
style
left-column

配列情報

[{"linker":null,"sequence":"MGSSHHHHHHSSGLVPRGSHMGSHMHRRGVGAGAIAKKKLAEAKYKERGTVLAEDQLAQMSKQLDMFKTNLEEFASKHKQEIRKNPEFRVQFQDMCATIGVDPLASGKGFWSEMLGVGDFYYELGVQIIEVCLALKHRNGGLITLEELHQQVLKGRGKFAQDVSQDDLIRAIKKLKALGTGFGIIPVGGTYLIQSVPAELNMDHTVVLQLAEKNGYVTVSEIKASLKWETERARQVLEHLLKEGLAWLDLQAPGEAHYWLPALFTDLYSQEITAEEAREALP","proteinLength":"Full Length","predictedMolecularWeight":"31.4 kDa","actualMolecularWeight":null,"aminoAcidEnd":258,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"Q96H20","tags":[{"tag":"His","terminus":"N-Terminus"}]}]
style
left-column

出荷温度及び保存条件

製品の状態
Liquid
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
False
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

EAP30 also known as VPS22 or SNF8 is a component of the ESCRT-II complex with a mass of approximately 30 kDa. It plays an important role in the endosomal sorting process a mechanism that directs the transport of ubiquitinated transmembrane proteins for lysosomal degradation. EAP30 is expressed in various tissues but shows high expression levels in cells involved in membrane trafficking and processes requiring active protein sorting.
Biological function summary

The EAP30 protein functions as part of the ESCRT-II complex which is essential for the formation of multivesicular bodies (MVBs) and their sorting machinery. EAP30 interacts with other components of the ESCRT machinery such as EAP20 and VPS36 ensuring effective processing of cellular signaling receptors and achieving membrane dynamics. This interaction facilitates the correct trafficking of membrane proteins which is necessary for maintaining cellular homeostasis.

Pathways

EAP30 is deeply integrated into the endosomal-lysosomal pathway which is essential for directing proteins toward lysosomal degradation. The protein operates closely with the ESCRT complex including ESCRT-I and ESCRT-III and is involved in endocytosis and receptor downregulation. It coordinates with proteins like VPS4 during late stages of vesicle budding and abscission essential for accurate vesicle scission events.

Malfunctions in EAP30 activities can relate to neurodegenerative conditions such as Alzheimer's disease and frontotemporal dementia. EAP30's incorrect function could impair protein degradation processes leading to the accumulation of ubiquitinated proteins. The protein also shows connections with components like TSG101 which further roles in vesicular transport perturbations seen in these diseases indicating possible therapeutic targets for intervention strategies.
style
left-column

一般的な情報

機能

Component of the endosomal sorting complex required for transport II (ESCRT-II), which is required for multivesicular body (MVB) formation and sorting of endosomal cargo proteins into MVBs, and plays a role in autophagy (PubMed : 38423010). The MVB pathway mediates delivery of transmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-II complex is probably involved in the recruitment of the ESCRT-III complex. The ESCRT-II complex may also play a role in transcription regulation by participating in derepression of transcription by RNA polymerase II, possibly via its interaction with ELL. Required for degradation of both endocytosed EGF and EGFR, but not for the EGFR ligand-mediated internalization. It is also required for the degradation of CXCR4. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed : 22660413).

配列の類似性

Belongs to the SNF8 family.

細胞内局在性

Endosome membrane

style
left-column

製品プロトコール

style
left-column

ターゲットの情報

Component of the endosomal sorting complex required for transport II (ESCRT-II), which is required for multivesicular body (MVB) formation and sorting of endosomal cargo proteins into MVBs, and plays a role in autophagy (PubMed : 38423010). The MVB pathway mediates delivery of transmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-II complex is probably involved in the recruitment of the ESCRT-III complex. The ESCRT-II complex may also play a role in transcription regulation by participating in derepression of transcription by RNA polymerase II, possibly via its interaction with ELL. Required for degradation of both endocytosed EGF and EGFR, but not for the EGFR ligand-mediated internalization. It is also required for the degradation of CXCR4. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed : 22660413).
See full target information SNF8
style
left-column
style
left-column
style
right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com